Evidence map›Paper›PMID 32607024›Full record

ArticleRisk management and healthcare policy2020

Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients.

Sophon Siwachat, Nirush Lertprasertsuke, Narumon Tanatip, Sarawut Kongkarnka, Juntima Euathrongchit, Yutthaphan Wannasopha, Thatthan Suksombooncharoen, Busayamas Chewaskulyong, Wil Lieberman-Cribbin, Emanuela Taioli and 2 more

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sophon Siwachat *Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nirush Lertprasertsuke *Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Narumon TanatipDepartment of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sarawut KongkarnkaDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Juntima EuathrongchitDepartment of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Yutthaphan WannasophaDepartment of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Thatthan SuksombooncharoenDepartment of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-1996-3387
Busayamas ChewaskulyongDepartment of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-4052-5728
Wil Lieberman-CribbinDepartment of Population Health Science and Policy, Institute for Translational Epidemiology, Icahn Medical School at Mount Sinai, New York, NY, USA.
Emanuela TaioliDepartment of Population Health Science and Policy, Institute for Translational Epidemiology, Icahn Medical School at Mount Sinai, New York, NY, USA.
Somcharoen SaetengDepartment of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Apichat TantraworasinDepartment of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0002-7913-2799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to identify the association between Thailand's insurance types and stage at presentation, surgical approach, tumor recurrence and cancer-specific survival in resectable non-small cell lung cancer (NSCLC) patients in northern Thailand. PATIENTS AND

methodsMedical records of patients with NSCLC who underwent pulmonary resection at Chiang Mai University Hospital from January 2007 through December 2015 were retrospectively reviewed. Patients were divided into two groups: patients with the Universal Coverage Scheme (UCS) or Social Security Scheme (SSS) and patients with the Civil Servant Medical Benefit Scheme (CSMBS) or private insurance (PI). Patient characteristics were assessed. The primary outcome was cancer-specific survival while the secondary outcome was tumor recurrence. Cox's regression and matching propensity score analysis was used to analyze data.

resultsThis study included 583 patients: 344 with UCS or SSS and 239 with CSMBS or PI. Patients with UCS or SSS were more likely to be active smokers, have a lower percent predicted FEV1, present with higher-stage tumors and worse differentiated tumors, present with tumor necrosis, and undergo an open surgical approach than those with CSMBS or PI. At multivariable analysis of all patients cohort, there were no significant differences in terms of early stage at presentation (adjusted odds ratio (OR

conclusionThai insurance types have an effect on cancer-specific survival. The Thai government should recognize the importance of these differences, and further multi-center studies with a larger sample size are warranted to confirm this result.

Indexed as

cancer deathCivil Servant Medical Benefit Schemecoveragepulmonary resectionSocial Security SchemeUniversal Coverage Scheme

Identifiers

PMID32607024
PMCPMC7297449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.